Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRESERVE Heart Study: A Prospective, Multi-center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart PRESERVation From Extended Donors

NCT05881278 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.

NCT NCT05881278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05881278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRESERVE Heart Study: A Prospective, Multi-center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart PRESERVation From Extended Donors
Lead sponsor
XVIVO Perfusion
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 10, 2023
Completion date
November 30, 2029
Enrollment
141 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, transplant; failure, heart